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ABSTRAK
Latar belakang: nefropati diabetik (ND) adalah penyebab terpenting dialisis di dunia. Penelitian terdahulu 
menunjukkan keterkaitan antara polimorfisme A1166C gen AT1R dan keadaan hiperfiltrasi glomerulus pada 
patogenesis ND. Diperlukan penelitian yang bertujuan untuk membuktikan hubungan antara polimorfisme 
A1166C AT1R dan kerentanan individu yang menderita diabetes melitus tipe 2, khususnya pada populasi Melayu, 
terhadap ND. Metode: penelitian ini merupakan studi analitik observasional dengan desain kasus-kontrol, 
melibatkan 120 pasien diabetes melitus tipe 2 (DMT2), 40 pasien untuk tiap kelompok makroalbuminuria, 
mikroalbuminuria, dan normoalbuminuria sebagai kontrol, dengan metode consecutive sampling. Adanya 
polimorfisme gen A1166C AT1R diperiksa dengan metode PCR/RFLP. Hasil: alel C mutan ditemukan 
sebanyak 5% pada kelompok normoalbumnuria, 13.75% pada kelompok mikroalbuminuria, dan 12.5% pada 
kelompok makroalbuminuria. Genotipe heterozigot AC ditemukan secara signifikan lebih tinggi pada kelompok 
mikroalbuminuria, dibandingkan dengan kelompok normoalbuminuria. Genotipe AC (OR 3.2 [1.01-10.08], 
p=0.03) dan alel C (OR 2.8[0.95-8.67], p=0.038) ditemukan lebih tinggi pada kelompok ND, menandakan 
polimorfisme A1166C gen AT1R sebagai faktor risiko ND pada pasien DMT2 ras melayu. Kesimpulan: terdapat 
hubungan antara polimorfisme A1166C gen AT1R dengan kejadian ND pada pasien DMT2 di populasi melayu 
Indonesia. Juga ditemukan bahwa polimorfisme A1166C gen AT1R kemungkinan berperan dalam penurunan 
fungsi ginjal pada pasien DMT2 sejak tahap awal.
Kata kunci: angiotensin II tipe-1 reseptor, polimorfisme, nefropati diabetik.
ABSTRACT
Background: diabetic nephropathy (DN) is the leading cause of blood dialysis worldwide and a major 
etiology of End-Stage Renal Disease cases in Indonesia. Previous studies showed a relevant link between 
A1166C polymorphism of Angiotensin II Type-1 Receptor (AT1R) gene and glomerular hyper-filtration as 
a part of pathogenesis of DN. The aim of this study was to elaborate the association between A1166C AT1R 
polymorphism and susceptibility of individual with type-2 diabetes to DN in Malay Indonesian population. 
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Methods: a case-control study of 120 consecutive patients with type-2 diabetes mellitus (40 patients in each 
groups for macro-albuminuria, micro-albuminuria, and normo-albuminuria) was conducted for A1166C AT1R 
gene polymorphism. The A1166C polymorphism of the AT1R gene was determined based on PCR/RFLP. Results: 
the mutant C allele was found in 5%, 13.75%, and 12.5% in normo-, micro-, and macro-albuminuria patients 
respectively. The heterozygote AC genotype was found significantly higher in micro-albuminuria, compared to 
normo-albuminuria group. Heterozygote AC genotype (OR 3.2 [1.01-10.08], p=0.03) and C allele (OR 2.8[0.95-
8.67], p=0.038) were significantly higher in DN, indicating A1166C AT1R gene polymorphism as a risk factor for 
DN in Malay Indonesian population with type-2 diabetes. Conclusion: there was positive association between 
A1166C AT1R polymorphism and susceptibility of type-2 diabetics to DN in Malay Indonesian Population. It 
also indicated that the A1166C AT1R polymorphism could play a role in early pathogenesis of DN.
Keywords: angiotensin II type-1 receptor, polymorphism, diabetic nephropathy.
INTRODUCTION
Diabetic nephropathy (DN) is the leading 
cause of end stage renal disease (ESRD) and 
blood dialysis worldwide1. DN accounts for 22% 
of ESRD in Indonesia.2 Playing a significant 
role for mortality in type-2 diabetes mellitus, 
DN affects almost 35% of patient with diabetes 
regardless of their glycemic control.3 Despite the 
identification of risk factors, such as duration of 
diabetes, hypertension, hyperglycemia, chronic 
inflammation, and genetic components, no clear 
single etiologic entity of DN has been identified. 
The understanding of genetic susceptibility 
in DN, which has been affirmed by previous 
familial studies, can elucidate the pathogenesis, 
and lead to better treatment and prevention efforts 
of DN.4,5
The angiotensin II type 1 receptor (AT1R), 
found mostly in the kidney and vascular 
smooth muscle,6 may have a role in the natural 
history of DN. AT1R is a G-protein coupled 
receptor,7 which angiotensin II binds to produce 
proliferation, vasoconstriction, and cellular 
effects.8 Some AT1R gene polymorphism have 
been identified, and the A1166C polymorphisms 
is the most studied. The A1166C polymorphism 
of AT1R gene due to a base replacement of 
cytosine for adenine at the position 1166 in 
the 3’untranslated region is related to the 
posttranslational modification of AT1R mRNA.9 
Previous studies has found that a mutant C 
allele was associated with an increased filtration 
fraction response to angiotensin II infusion,10 
thereby indicating the augmented angiotensin 
II activity in the presence of C allele and thus 
enabling glomerular hyper-filtration, an early 
classical finding for micro-albuminuria stage 
of DN.11
Several previous studies have investigated 
the role of AT1R polymorphism in the involute 
etiology of DN although they showed conflicting 
results. Those studies have signified12 or 
refuted13,14 the role of A1166C AT1R gene 
variant in the natural history of type-2 DN. 
The inconsistent finding among studies is 
accredited to the genetic diversity and ethnicity 
background among various populations. We 
accordingly opted to explain for the first time 
the plausible association between the A1166C 
AT1R polymorphic variants and DN in an 
Malay Indonesian diabetic population, as there 
is an absence of the comparable studies in an 
Indonesian population. The aim of this study 
was to elaborate the association between A1166C 
AT1R polymorphism and susceptibility of 
individual with type-2 diabetes to DN. In an 
attempt to gather better explanation about the role 
of the A1166C AT1R polymorphism in natural 
history of DN, we eleborated DN into its two 
group stages, which were micro-albuminuria and 
macro-albuminuria.
METHODS
An observational analytic study with a case-
control design was conducted at an outpatient 
clinic and inpatient wards in Mohammad Hoesin 
General Hospital Palembang, South Sumatera. 
All consecutive patients were recruited. Written 
informed consent were obtained from all 
patients. The study was approved by the local 
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Ethics Committee from health research review 
committee of Mohammad Hoesin General 
Hospital and Faculty of Medicine Universitas 
Sriwijaya on January 9th, 2012, with a reference 
number 004/KEPKRSMHFKUNSRI/2011.
The study population consisted of an Malay 
Indonesian population with diabetes who had 
resided in South Sumatera for three generations. 
The minimum sample needed was 38 patients for 
each group. The inclusion criteria for case group 
were subjects with type-2 diabetes aged 40-65 
years old, with DN, and normal renal function- 
defined by estimated Glomerular Filtration 
Rate (GFR) more than 60 mL/min/1.73m2. For 
the control group, the sex-and-age-matched 
individual with type-2 diabetes with normo-
albuminuria (i.e. urinary albumin excretion below 
30 µg/mg creatinine) were included. Diagnosis 
of diabetes was made according to the American 
Diabetes Association Standard Medical of Care 
which was adapted to Indonesian National 
Consensus on Type-2 Diabetes Mellitus.15,16 
The diagnosis of nephropathy was based on 
at least two consecutive occasions of micro-
albuminuria (urinary albumin excretion 30-300 
µg/mg creatinine) or macro-albuminuria (urinary 
albumin excretion above 300 µg/mg creatinine) 
as a minimum criterion in non-oliguric patients 
with diabetic retinopathy without any other 
possible cause.16 In order to exclude the cause 
of proteinuria other than diabetes, those with 
evidence of previous renal disease that could 
be the secondary causes of albuminuria such 
as glomerulonephritis, nephro-ureterolithiasis, 
chronic infections, malignancy, and obstructive 
uropathy were not eligible to participate in the 
study.
Genetic Analysis
2 mL of peripheral blood, were drawn by 
venipuncture in the upper limbs and placed into 
tubes containing 5% EDTA. Genomic DNA 
was then isolated from leukocytes and DNA 
was extracted by standard techniques.17 A1166C 
polymorphism of the AT1R gene were determined 
by polymerase chain reaction (PCR or restriction 
fragment length polymorphism (RFLP) using 
modified method of previous studies.18
For the detection of A1166C polymorphism 
in 3’ untranslated region, the primer used were 
5’GCA CCA TGT TTT GAG GTT-3’ for sense 
primer and 5’CGA CTA CTG CTT AGC ATA-
3’ for antisense primer. The PCR product was 
527 base pairs (bp) fragment. After digesting 
with DdeI RFLP enzyme for 3 hours, the PCR 
products was detected on 2% agarose gel 
electrophoresis stained with ethidium bromide 
(Biorad, Hercules, California USA). Wild 
type allele, allele A, generated one fragment 
corresponding to size 527 bp. Two fragments 
of 417 bp and 110 bp were observed as mutated 
allele C. The heterozygote genotype would 
generate three fragments of 417, 110, and 527 bp.
Statistical Analysis
Values were presented as mean and standard 
deviations. The fisher exact test or chi square test 
was used for analysis of the categorical variables, 
and ANOVA was used for continuous variables 
with normal distribution. The association 
between A1166C AT1R gene polymorphism and 
DN susceptibility was assessed by calculating 
the odds ratios. P-values of less than 0.05 were 
considered to be significant. Statistical analysis 
was performed using SPSS 16.0 for Windows.
RESULTS
We generated the genotype of total 120 
patients with type-2 diabetes mellitus there 
was 40 patients for each groups for macro-
albuminuria, micro-albuminuria, and normo-
albuminuria. Demographic, clinical, and 
laboratorial characteristics of all patients are 
shown in Table 1. There were no significant 
difference among groups’ demographic and 
clinical characteristics. The patients with 
DN, both micro and macro-albuminuria, had 
significantly lower hemoglobin level. They also 
tend to have significantly higher level of serum 
creatinine.
The allele frequency and the genotype 
distribution of A1166C polymorphism in the 
groups of patient according to the clinical 
profile (macro-albuminuria, micro-albuminuria, 
and normo-albuminuria) are shown in Table 
2. The heterozygote genotype was found to 
be significantly higher in patients with micro-
albuminuria compared to normo-albuminuria. 
There was no CC genotype found. Based on 
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Table 1. Characteristics of the patients
Variables




 - Male 12 (30) 15 (37.5) 15 (37.5) 0.721
 - Female 28 (70) 25 (62.5) 25 (62.5)
Diabetes duration (years),  
mean (SD)
5.98 (3.20) 7.98 (3.81) 6.57 (4.09) 0.052
Age (years), mean (SD) 52.60 (9.19) 54.80 (5.81) 54.03 (4.89) 0.352
Body Mass Index (kg/m2), mean (SD) 21.28 (1.43) 21.53 (2.33) 21.86 (1.65) 0.372
SBP (mmHg), mean (SD) 135.75 (11.07) 137.50 (15.48) 126.27 (24.01) 0.012*
DBP (mmHg), mean (SD) 83.25 (7.64) 85.75 (9.0) 81.75 0.92
Hemoglobin (g/dl), mean (SD) 12.35 (0.84) 12.54 (0.97) 12.95 (1.24) 0.032*
HbA1C (%), mean (SD) 8.91 (2.11) 8.76 (2.34) 7.86 (1.94) 0.062
Blood Urea (mg/dl), mean (SD) 31.58 (11.34) 33.20 (12.42) 28.75 (8.09) 0.182
Creatinine (mg/dl), mean (SD) 0.73 (0.19) 0.92 (0.18) 0.64 (0.11) 0.002*
Note: SBP, systolic blood pressure; DBP, diastolic blood pressure; 1fisher exact test; 2one way ANOVA; *p<0.05
their clinical diagnosis as shown in Table 3, 
it was found that AC genotype (OR 3.2 [1.01-
10.08], p=0.03) and C allele (OR 2.8[0.95-8.67], 
p=0.038) were significantly higher in DN.
DISCUSSION
According to our knowledge, this study was 
the first to investigate AT1R polymorphisms in 
the Indonesian with type-2 diabetes, specifically 
in the Malay ethnic group. The corroboration 
for the role of this gene in the pathophysiology 
of DN comes from studies in diabetics who 
had mutated C allele of A1166C AT1R that 
asserted the infusion of angiotensin II which 
leads to increased filtration fraction,10,19 an early 
pathogenesis hallmark of micro-albuminuria 
stage of DN.
AT1R is a G-coupled protein that is found 
mostly on kidney and systemic vasculature.6 
It mediates the effects of angiotensin II on 
vasoconstriction and cell transport of molecules. 
In the glomerulus of the kidney, the expression 
of AT1R was localized mostly in the podocytes.20 
An in vivo study on nephropathy-induced female 
Brown Norway mice observed an overexpression 
of AT1R correlated to proteinuric state.21 The 
study also highlighted the inhibition of AT1R 
which improved the proteinuria mainly caused 
by the reduction of functional protein on slit 
diaphragm. Glomerular slit diaphragm is a 
membrane-like structure of glomerular basal 
membrane that functions as a barrier which averts 






n=40 (Ma) p OR (95% CI)
Genotype Distribution 
 - AA 36 (90) 29 (72.5) 30 (75) 0.04* Mi to N = 3.41 (1.03-11.86)
 - AC 4 (10) 11 (27.5) 10 (25) 0.07 Ma to N = 3.01 (0.85-10.54)
 - CC 0 (0) 0 (0) 0 (0) 0.5 Mi to Ma = 1.13 (0.41-3.08)
Allelic Frequency
 - A 76 (95) 69 (86.25) 70 (87.5) 0.05 Mi to N = 3.02 (0.92-9.95)
 - C 4 (5) 11 (13.75) 10 (12.5) 0.08 Ma to N = 2.7 (0.81-9.04)
0.5 Mi to Ma = 0.89 (0.35-2.24)
Note: chi square test, *p=<0.05; Mi: Micro-albuminuria; Ma: Macro-albuminuria; N: Normo-albuminuria. 1Odds Ratio for 
heterozygote AC genotype/ mutant C allele between selected groups.
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plasma proteins leakage into urine.20 In patients 
with DN, the slit diaphragm damage is a focus 
of novel targeted therapy.22
Previous studies found that A1166C allele 
frequencies varied widely, depending on ethnic 
heterogeneity. Moradi et al13 reported the 
prevalence of the C allele in Iranian (15.3%). 
Our study did not find any mutant homozygote 
CC genotype. Doria et al18 which conducted a 
research in USA and Fradin et al12 which was 
conducted in Caucasian French found 9% and 
3% CC genotype respectively. Our study found 
that the mutated C allele frequency was 13.1% 
in patients with type-2 DN, which was similar 
to the studies in Iranian type-2 DN patients 
(13.2%)13 and lower than that observed in French 
Caucasian (23.9%).12
Our study showed that significant difference 
in genotype distribution was only found between 
micro-albuminuria and normo-albuminuria, and 
there was no significant difference in macro-
albuminuria. Altogether, these findings are 
interpreted to support the hypothesis that the 
A1166C polymorphisms might play a role in the 
early pathogenesis of DN.10,11 There was also no 
significant difference in allele frequency among 
three groups. Similar findings were identified in 
study by Chang et al14 which found no significant 
difference in allele frequency among normo-, 
micro-, and macro-albuminuria Taiwan Chinese 
type-2 DN patients.
A different findings were identified, when 
comparing heterozygote AC genotype and C 
allele distribution in DN to non-DN group. 
Heterozygote AC genotype and C allele was 3.2 
times and 2.8 times in DN. These findings support 
the hypothesis that A1166C polymorphism was 
a risk factor for the susceptibility of type-2 
diabetics to DN. A similar result was found in 
French Caucasian.12 Intriguingly, different results 
were found in two other studies in Asian13,14 
which identified null association between 
A1166C polymorphism and type-2 DN.
There is a chance that the negative findings 
in mutant homozygote CC genotype is the caused 
of a selective loss in this study. Further studies 
in larger sample size is needed. In spite of this 
limitation, our study was the first published 
attempt to elucidate the association between 
AT1R polymorphism and DN in Indonesian 
population which provides definitive support for 
the role of AT1R polymorphism in type-2 DN.
CONCLUSION
In conclusion,  A1166C AT1R gene 
polymorphism is a risk factor for DN among 
Indonesian Malay type-2 diabetics. Our study 
also indicated that A1166C AT1R polymorphism 
could play a role in early pathogenesis of DN.
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